跳至主要内容
临床试验/IRCT201010044865N1
IRCT201010044865N1已完成未知

Evaluation of the effect of intravenous Carnitine on hemoglobin and hematocrit level in chronic renal disease patients who are under hemodialysis treatment

Zanjan University of Medical Sciences0 个研究点目标入组 29 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
29

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Hb less than10mg/dl, patients who had dialysed at least for one year, ferritin more than or equal to 100, SI/TIBC more than 20%, normal LFT, PTH less than or equal to 150pg/ml, negative ß-HCG in female patients
  • Exclusion criteria: receiving carnitine in 2 months prior to the study, pregnancy (positive ß-HCG), Liver disease, ferritin less than 100, SI/TIBC less than 20%, PTH more than 150pg/ml

排除标准

  • 未提供

研究者

相似试验